Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ACADIA Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ACAD
Nasdaq
2836
www.acadia.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ACADIA Pharmaceuticals Inc.
High Growth Tech Stocks to Watch in US February 2026
- Feb 5th, 2026 10:38 am
High Growth Tech Stocks In The US For February 2026
- Feb 5th, 2026 4:38 am
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
- Feb 4th, 2026 2:05 pm
Exploring US High Growth Tech Stocks This February 2026
- Feb 3rd, 2026 10:38 am
Acadia Pharmaceuticals' Rett Syndrome Medication Less Likely to Receive EU Approval, RBC Says
- Feb 3rd, 2026 9:02 am
Acadia Expects Negative CHMP Opinion for Rett Syndrome Drug in EU
- Feb 3rd, 2026 5:52 am
High Growth Tech Stocks to Watch in the US Market
- Feb 3rd, 2026 4:38 am
FDA launches ‘PreCheck’ program; AstraZeneca, Acadia drugs set back
- Feb 3rd, 2026 3:11 am
The Bull Case For ACADIA Pharmaceuticals (ACAD) Could Change Following EMA Setback For Trofinetide Approval
- Feb 3rd, 2026 1:11 am
Acadia Faces EMA Setback On Rett Drug As Regulatory Test Looms
- Feb 2nd, 2026 9:35 pm
Is It Too Late To Consider ACADIA Pharmaceuticals (ACAD) After Its Recent Share Price Rebound?
- Feb 2nd, 2026 7:13 pm
Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union
- Feb 2nd, 2026 2:05 pm
Why Acadia (ACAD) is Poised to Beat Earnings Estimates Again
- Feb 2nd, 2026 10:10 am
FTRE or ACAD: Which Is the Better Value Stock Right Now?
- Jan 28th, 2026 9:40 am
Auvelity Continues to Aid AXSM's Top Line: More Upside in 2026?
- Jan 26th, 2026 8:15 am
High Growth Tech Stocks To Watch In The US January 2026
- Jan 22nd, 2026 4:38 am
A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Swings
- Jan 14th, 2026 9:08 am
Is It Time To Reassess ACADIA Pharmaceuticals (ACAD) After Its Recent Share Price Surge
- Jan 14th, 2026 3:10 am
ACADIA Pharmaceuticals Targets $1.7B Sales by 2028, Maps Key Remlifansirin Readouts at JPM Conf
- Jan 13th, 2026 12:06 pm
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
- Jan 13th, 2026 7:00 am
Scroll